Pharmacologic Activation of P53 by Small-Molecule MDM2 Antagonists

Current Pharmaceutical Design - United Arab Emirates
doi 10.2174/138161211795222603
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.

Chemistry and Biodiversity
Molecular MedicineMolecular BiologyBiochemistryMedicineBioengineeringChemistry
2019English

Activation of P53 by MDM2 Antagonists Has Differential Apoptotic Effects on Epstein–Barr Virus (EBV)-positive and EBV-negative Burkitt's Lymphoma Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

HDMX and Mdm2 Can Repress Transcription Activation by P53 but Not by P63

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Acetylation of P53 Inhibits Its Ubiquitination by Mdm2

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Small Molecule Receptor Agonists and Antagonists of CCR3 Provide Insight Into Mechanisms of Chemokine Receptor Activation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Stabilization of the MDM2 Oncoprotein by Mutant P53

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Accelerated MDM2 Auto-Degradation Induced by DNA-damage Kinases Is Required for P53 Activation

EMBO Journal
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2004English

MDM2 Inhibitor, Nutlin 3a, Induces P53 Dependent Autophagy in Acute Leukemia by AMP Kinase Activation

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy